Questo è quello che abbiamo trovato per te
This 2022 Recommendation Statement from the US Preventive Services Task Force recommends screening for anxiety in children and adolescents aged 8 to 18 years (B recommendation) and concludes that current evidence is insufficient to assess the balance of benefits and harms of screening for anxiety in children 7 years or younger (I statement).
This JAMA Patient Page summarizes the US Preventive Services Task Force’s recent recommendations on screening for anxiety in children and adolescents.
This systematic review to support the 2022 US Preventive Services Task Force Recommendation Statement on screening for anxiety in children and adolescents summarizes published evidence on the benefits and harms of screening for and treatment of anxiety in children and adolescents 18 years or younger.
In this issue of JAMA, the US Preventive Services Task Force (USPSTF) presents a Recommendation Statement on screening for anxiety in children and adolescents, based on an Evidence Report and Systematic Review by Viswanathan et al that summarized the evidence for screening and treatment. In its current report, the USPSTF “recommends screening for anxiety in children and adolescents aged 8 to 18 years (B recommendation)” and “concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for anxiety in children 7 years or younger (I statement).”
New England Journal of Medicine, Ahead of Print.
New England Journal of Medicine, Ahead of Print.
The Asia-Pacific region has the largest number of cases of colorectal cancer (CRC) and one of the highest levels of mortality due to this condition in the world. Since the publishing of two consensus recommendations in 2008 and 2015, significant advancements have been made in our knowledge of epidemiology, pathology and the natural history of the adenoma-carcinoma progression. Based on the most updated epidemiological and clinical studies in this region, considering literature from international studies, and adopting the modified Delphi process, the Asia-Pacific Working Group on Colorectal Cancer Screening has updated and revised their recommendations on (1) screening methods and preferred strategies; (2) age for starting and terminating screening for CRC; (3) screening for individuals with a family history of CRC or advanced adenoma; (4) surveillance for those with adenomas; (5) screening and surveillance for sessile serrated lesions and (6) quality assurance of screening programmes. Thirteen countries/regions in the Asia-Pacific region were represented in this exercise. International advisors from North America and Europe were invited to participate.
This cohort study uses US Veterans Health Administration data to assess the association of prostate-specific antigen screening with prostate cancer–specific mortality among non-Hispanic Black men and non-Hispanic White men.
This cohort study of data on participants in the Cardiovascular Health Study assesses risk of lung cancer in smokers for whom low-density computed tomographic screening is not recommended.
Introduction
Sleep disorders are still often underestimated in patient care management even though they are present in the criteria of the American College of Rheumatology for the diagnosis of fibromyalgia syndrome (FMS). The objective of this study will be to assess the current situation of sleep disorders in patients with FMS in France and to estimate its prevalence.
Methods and analysis
The FIBOBS study is a multicentred, prospective, observational trial performed by 46 specialised chronic pain structures in France. Patients with FMS visiting for a first consultation or follow-up (if they have already been followed up for less than a year with a pain management service) will be included after giving their informed consent. Data will be collected through the physician questionnaire filled during the inclusion visit. Patient self-questionnaires will be completed from home. The primary outcome of the study will be to estimate the prevalence of sleep disorders classified into three categories: (a) poor sleep quality in general, (b) sleep apnoea syndrome and (c) restless legs syndrome, using self-administered questionnaires.
Ethics and dissemination
This protocol is approved by the ethics committee Comité de Protection des Personnes ‘Ile de France II’ in accordance with French regulations. The results will be disseminated through peer-reviewed journals and conferences.
Trial registration number
NCT04775368.
Fracture prediction is not improved significantly by repeat BMD measurement.
Annals of Internal Medicine, Volume 175, Issue 10, Page 1366-1373, October 2022.
Annals of Internal Medicine, Ahead of Print.
Annals of Internal Medicine, Ahead of Print.
Objective
To evaluate the performance of the fibrosis-4 (FIB-4) score as a screening tool to detect significant liver fibrosis (F2) compared with transient elastography (TE), among chronic transfusion-dependent beta-thalassaemia (TDT) patients in a resource-poor setting.
Design
A cross-sectional study.
Setting
Adolescent and Adult Thalassaemia Care Centre (University Medical Unit), Kiribathgoda, Sri Lanka.
Participants
45 TDT patients who had undergone more than 100 blood transfusions with elevated serum ferritin >2000 ng/mL were selected for the study. Patients who were serologically positive for hepatitis C antibodies were excluded.
Outcome measures
TE and FIB-4 scores were estimated at the time of recruitment in all participants. Predefined cut-off values for F2, extracted from previous TE and FIB-4 scores studies, were compared. A new cut-off value for the FIB-4 score was estimated using receiver operating characteristics curve analysis to improve the sensitivity for F2 prediction.
Results
Of the selected 45 TDT patients, 22 (49%) were males. FIB-4 score showed a significant linear correlation with TE (r=0.52;p
